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Abstract8
9
Within this work we present a ‘proof of principle’ study for the use of scanning10
electrochemical microscopy (SECM) to detect and image biomolecular interactions in a11
label-free assay as a potential alternative to current fluorescence techniques.12
Screen-printed carbon electrodes were used as the substrate for the deposition of a dotted13
array, where the dots consist of biotinylated polyethyleneimine. These were then further14
derivatised, first with neutravidin and then with a biotinylated antibody to the protein15
neuron specific enolase (NSE). SECM using a ferrocene carboxylic acid mediator16
showed clear differences between the array and the surrounding unmodified carbon.17
Imaging of the arrays before and following exposure to various concentrations of the18
antigen showed clear evidence for specific binding of the NSE antigen to the antibody19
derivatised dots. Non-specific binding was quantified. Control experiments with other20
proteins showed only non-specific binding across the whole of the substrate, thereby21
confirming that specific binding does occur between the antibody and antigen at the22
2surface of the dots. Binding of the antigen was accompanied by a measured increase in23
current response, which may be explained in terms of protein electrostatic interaction and24
hydrophobic interactions to the mediator, thereby increasing the localised mediator flux.25
A calibration curve was obtained between 500 fg mL-1 to 200 pg mL-1 NSE which26
demonstrated a logarithmic relationship between the current change upon binding and27
antigen concentration without the need for any labeling of the substrate.28
29
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1. Introduction33
34
In recent years there has been an increasing demand for the development of parallel35
analytical testing platforms and this has led to increased research into miniaturised36
biosensors, biosensor arrays, and chip based testing systems. Within the commercial37
market it is already possible to obtain DNA-based testing systems, however there is still38
an unmet need when considering the use of proteins as the functional units. This is39
possibly due in part to proteins being less stable and also their characteristic to denature40
once in contact with the surface to which they are immobilized.41
42
The incorporation of antibodies into conducting polymer films was first reported in 199143
[1]. Anti-human serum albumin (anti-HSA) was incorporated into a (poly)pyrrole film,44
which was galvonostatically polymerized onto a platinum wire substrate. When the45
3pyrrole anti-HSA was exposed to 50 µg mL-1 HSA for 10 min, a new reduction peak was46
observed at a potential of +600 mV versus Ag/AgCl. Since this preliminary work there47
has been an increase in the development of electrochemical immunosensors, as reviewed48
previously elsewhere [2-4].49
50
Previous work within our group has shown that up to 2-3 µg of antibodies for bovine51
serum albumin (BSA) and digoxin may be successfully incorporated into conducting52
polymer films by entrapment in an electrochemically grown (poly)pyrrole film with no53
detrimental effect to antibody activity [5]. Further work utilized an ac impedance protocol54
as the method for interrogation for these films [6]. A protocol was then developed for55
immobilizing antibodies onto polyaniline-coated screen printed carbon electrodes which56
utilized the classical avidin-biotin interaction. This enabled the construction of57
immunosensors for the antibiotic ciprofloxacin [7, 8], the heart drug digoxin [9] and for58
myelin basic protein [10] - which could detect their respective targets with detection59
limits of 1 ng mL-1 of the target species. Later work utilized polyaniline microarrays as a60
substrate for the assembly of immunosensors for prostate specific antigen (PSA) [11] and61
the stroke marker proteins neuron specific enolase (NSE) [12] and S100[β] [13], with62
greatly lowered limits of detection down to the level of 1 pg mL-1 of the target.63
64
Biotin/avidin chemistry has been used extensively to modify electrode surfaces by protein65
immobilization. The attachment of a biotin molecule allows the immobilization of any66
biomolecule of the avidin family. Neutravidin protein is a deglycosylated version of67
avidin with four identical binding sites. It has a near neutral isoelectric point (IEP) which68
4minimizes non-specific interaction and like avidin itself has a strong affinity with biotin69
(kD = 10-15 M-1) [14,15]. Due to this strong interaction, the complex formation is nearly70
unaffected by extremes of pH or temperature, organic solvents, and denaturing agents.71
The tetravalent binding of neutravidin to biotin allows the construction of a molecular72
sandwich effect where the bound neutravidin is free to couple to a biotinylated antibody73
with the appropriate characteristics needed for the construction of a biosensor.74
75
Enolase is a 78 kDa homo- or heterodimeric cytosolic protein produced from [α], [β], and76
[γ] subunits. The [γ][γ] enolase isoform is most specific for neurons, and is referred to as 77 
NSE. Elevations of NSE in serum can be attributed to cerebral injury due to physical78
damage or ischemia caused by infarction or cerebral haemorrhage, coupled with79
increased permeability of the blood brain barrier. The serum concentration of NSE has80
also been reported to correlate with the extent of damage (infarct volume) and81
neurological outcome [16]. Additionally, a secondary elevation of serum NSE82
concentration may be an indicator of delayed neuronal injury resulting from cerebral83
vasospasm [17]. NSE, which has a biological half-life of 48 hours and is normally84
detected in serum at an upper limit of 12.5 ng mL-1 (160 pM), is typically elevated after85
stroke and cerebral injury. Serum NSE is elevated after 4 hours from onset, with86
concentrations reaching a maximum between 1-3 days after onset [18]. After the serum87
concentration reaches its maximum (maybe >300 ng mL-1, 3.9 nM), it gradually88
decreases to normal concentrations over approximately one week.89
90
5Scanning electrochemical microscopy (SECM) is a surface scanning probe technique that91
allows for the collection of high resolution electrochemical data on a variety of surfaces92
and has previously been used successfully to investigate various biological systems93
including cells [19-23], enzymes [24-27], and DNA [28-30].94
95
We have, within this work, attempted to utilize the SECM to detect the binding of96
antibody layers to electrodes and to determine if these systems can be used for the label-97
free detection of NSE. This work is intended as a ‘proof of principle’ study to show the98
feasibility of antigen adsorption and imaging rather than the fabrication of either a99
sensitive antigen sensor or the detailed examination of the polymer and biomolecular100
films absorbed. Once a proof of principle has been demonstrated we will in future work101
move towards studying a range of antigens of various molecular sizes and investigate the102
possibility of fabricating one array containing a number of different antibodies of interest.103
104
105
106
2. Experimental Section107
108
2.1 Chemicals and Reagents109
110
Ferrocene carboxylic acid, biotinylation kit (part no. BK101), neutravidin,111
polyethyleneimine (PEI) (MW = 50000) and BSA were purchased from Sigma-Aldrich112
(Gillingham, Dorset, UK). Disodium hydrogen orthophosphate monohydrate, sodium113
6dihydrogen orthophosphate 12-hydrate and sodium chloride (all ‘AnalaR’ grade) were114
purchased from BDH (Poole, Dorset, UK). All reagents were used without further115
purification. Commercial screen-printed carbon electrodes were obtained from116
Microarray Ltd. (Manchester, UK). NSE and monoclonal antibody against NSE - both117
with sodium azide preservative, and PSA were supplied by Canag Diagnostics, Ltd.118
(Gothenburg, Sweden).119
120
For antibody and PEI biotinylation, the procedure outlined in the BK101 kit was followed121
(see manufacturer’s instructions for details). Biotinylated antibodies were kept frozen in122
aliquots of 200 µl at a concentration of 0.2 mg mL-1 until required.123
All water used was purified with an ELGA Purelab UHQ-II water system (Elga High124
Wycombe, UK). Phosphate buffer (PBS), pH 7.0 contained NaH2PO4 (4 mmol mL-1),125
Na2HPO4 (6 mmol mL-1) and NaCl (132 mmol mL-1).126
127
SECM experiments were carried out using a Uniscan SECM270 (Uniscan Instruments128
Ltd, Buxton, UK). The SECM instrument (shown schematically in figure 1a) is composed129
of (1) an electrochemical cell, (2) a translational stage capable of high resolution130
movement in the X,Y and Z planes (sub-micron), (3) a bipotentiostat for the accurate131
control of the potential applied at the tip and/or substrate, (4) a hardware interface132
enabling the control of (1) and (2), and (5) a PC which provides an interface with the133
hardware – and allows the operator to accurately control the parameters of the SECM134
procedure. Pt counter electrodes and Ag/AgCl reference electrodes were also utilized as135
7shown in figure 1b. Ferrocene carboxylic acid (5 mmol l-1 in pH 7.0 phosphate buffer)136
was used as the mediator (figure 1c).137
138
2.2 Substrate patterning139
140
In the immunosensors previously developed within our laboratory, cyclic voltammetry141
was utilized to deposit polyaniline films on the carbon electrodes [7-13]. This was142
deemed inappropriate for the preparation of electrodes to be interrogated by SECM as it143
is not possible to compare a modified region with an unmodified region. Any changes in144
the tip current obtained may be due to fluctuations in the background current and not due145
to changes in the charge transfer properties of the modified substrate. It was therefore146
decided that for SECM interrogation, the polyelectrolyte film should be patterned in an147
array dot format. By producing this pattern, background effects in the measured current148
could therefore be eliminated and any changes in the current over the modified surface149
would contrast with the current over regions of unmodified carbon. Since it would not be150
possible to use polyaniline in this format it was decided to use PEI which has previously151
been used within the group when interrogating DNA arrays with SECM [30].152
153
A borosilicate glass capillary was pulled to an internal diameter of 80-100 µm using a154
Narishige PP-830 pipette puller (Narishige International Limited, London, UK) and the155
tip polished to a flat finish. This capillary was then filled with a 1% biotinylated PEI156
solution and, using the micropositioning stage on the Uniscan SECM270, used to157
fabricate a biotinylated PEI array (figure 2). Each of the dots were distanced 300 µm158
8centre to centre and approximately 200 µm in diameter. After patterning, the substrate159
was then rinsed with UHQ water. Once the area was dry 20 µl of neutravidin (10 mg160
mL-1 in water) were placed on the dotted microarray for 1 h, followed by rinsing with161
water. 20 µl of biotinylated antibody (0.2 mg mL-1 in water, 1 h) were then added162
followed by further rinsing. Finally non-specific interactions were blocked by BSA (10-6163
mol L-1 in PBS, 1 h).164
165
2.3 SECM studies166
167
A screen-printed carbon electrode substrate was placed in a plastic Petri dish and exposed168
to 5 mmol l-1 mediator solution. The SECM working electrode tip and counter and169
reference electrodes were then immersed into the mediator solution. Prior to undertaking170
an area scan over the antibody/PEI functionalized regions, an approach curve experiment171
was conducted over the polycarbonate, non-conductive region of the substrate to estimate172
the tip-to-substrate distance (Tip Potential (E) = +0.45 V vs. Ag/AgCl; step size = 10173
µm). The tip was positioned at a distance at which the measured current was half that of174
the observed current with the tip a few mm distant from the surface of the screen printed175
electrode (effectively infinite on this scale) (approximately 70 m from substrate176
surface); this was to allow for the variation in topography and the height differential177
between this non-carbon region and the slightly raised carbon electrode surface - while178
also serving to reduce the risk of tip crash. After tip positioning, an area scan over the179
functionalised region was conducted with a step size of 10 µm. At no point in the180
experiment was the substrate touched; this allowed any change in the observed tip current181
9to be attributed solely to changes in the charge transfer properties of the surface. In all182
cases the tip diameter was 8.5 µm; the scan rate used was 10 µm per step throughout and183
there was no potential applied to the substrate.184
185
After the first area scan experiment was conducted, the tip was retracted a known safe186
distance from the substrate. The mediator solution was then removed and the substrate187
gently rinsed with UHQ water before applying a solution containing complementary188
antigen over a range of concentrations or a non-complementary antigen. After exposure189
for 1 hour, the antigen solution was then removed and the substrate again rinsed before190
the re-introduction of fresh mediator solution. A second area scan experiment was then191
conducted over the same functionalised area as measured previously. The tip current data192
from the area scan before exposure was then subtracted from the tip current data193
following this exposure. Throughout all these experiments the sample substrate does not194
move at all, i.e. all exposures, rinsing steps etc are performed with the sample in situ. It is195
worth noting here that after each exposure and rinsing step the Petri dish is refilled with196
fresh mediator solution and the tip exactly repositioned, made possible using the XYZ197
micro-positioning stage of the SECM270. This allows precise and reproducible imaging198
of the same area of the electrode.199
200
3. Results and Discussion201
202
To ensure that changes occurring on the sensor surface were directly related to the203
hybridization of antibody and antigen, and not due to interference of mediator solution or204
10
poor stability of the substrate, surface scans were undertaken of the antibody modified205
dotted arrays (figure 3a). The modified surface displays an array of peaks which206
correspond to decreases in the tip current. This can be accounted for by the207
polymer/antibody composite acting as a barrier to mediator diffusion to the surface,208
thereby diminishing the current since polyelectrolytes are known to act as barriers to ion209
migration [31].210
211
After this initial scan, samples were incubated in purified water for 30 mins in parallel to212
the immunochemical exposures but in the absence of antigen. Following rinsing, fresh213
mediator solution was introduced. A scan of this surface is shown in figure 3b.214
Subtraction of figure 3a from 3b (figure 3c) clearly shows only minimal variations,215
indicating that minimal changes in background current are seen and that there is no loss216
of material from the surface. Other techniques employed to dot down the array were217
investigated. These included the direct dotting of antibody onto the carbon surface,218
however, these proved to be unstable and deterioration of the array could be visualised as219
the scan progressed.220
221
Binding experiments were performed by soaking the modified antibody dotted arrays in222
solutions of varying concentrations of the complementary antigen for 30 mins, followed223
by scanning in fresh mediator solution. A control was also run using 5 pg mL-1 PSA to224
ensure changes could be related to specific antigen/antibody binding rather than simple225
non-specific absorption of proteins to surfaces. Binding experiments were carried out226
using NSE solution with concentrations ranging from 500 fg mL-1 - 200 pg mL-1 in water.227
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Detailed results (figures 4a – c) are presented for the exposure to 200 pg mL-1. Figure 4a228
depicts the scan over the dotted array before incubation, with figure 4b showing the scan229
taken after exposure to 200 pg mL-1 NSE. Figure 4c shows the difference between the230
two scans indicating changes to the tip current over both the carbon surface and the231
dotted substrate. Figure 4c shows that across the whole of the array there is a general232
increase in measured tip current. The change in tip current is, however, seen to be much233
greater in the areas of the PEI/biotinylated antibody dots than for the untreated carbon234
surface.235
236
NSE is known to have both positively and negatively charged areas on the surface of the237
protein [32]. The cationic areas of the protein are capable of electrostatically attracting238
the ferrocene carboxylic acid (which is anionic at pH 7 due to ionisation of the acid239
group), thereby increasing the flux of the mediator to the microelectrode tip. There is also240
the possibility of hydrophobic interactions between the ferrocene unit and any241
hydrophobic regions of the NSE protein. These could effectively increase the242
concentration of ferrocene carboxylic acid at the surface and thus enhance the current243
flow.244
245
Evidence for this type of behaviour comes from earlier work on DNA where the charge246
on the mediator is found to determine the electrochemical response at the surface. DNA is247
an anionic polymer due to the presence of phosphate groups and when an anionic248
mediator is utilised (ferricyanide), increasing the amount of DNA at the surface by249
hybridisation led to a decrease in current transfer due to repulsion and inhibition of250
12
mediator diffusion [33]. However when a cationic hexaamine ruthenium mediator was251
used, increasing the amount of DNA led to an increase in current transfer [30]. This is252
thought to be due to the cationic mediator being bound by the anionic DNA, thereby253
increasing the local concentration of mediator at the surface and enhancing electron254
transfer between the surface and the probe tip. In a similar fashion we believe the binding255
of antigen causes a localised increase of mediator (in this case ferrocene carboxylic acid)256
by the same principle and leads to increased current transfer.257
258
The results demonstrate that NSE is bound at the surface in greater concentration in the259
modified areas, indicating that specific binding is indeed occurring. There appears to be260
some non-specific binding as shown by the increase in current over the unmodified261
carbon surface however, this non-specific binding was only observed a the highest262
concentration of 200 pg mL-1 and not when investigating the lower antigen263
concentrations. This confirms our earlier results obtained with microelectrode arrays.9264
Further confirmation was obtained by control experiments with PSA which showed a low265
level of non-specific binding over the entire surface but no specific binding to the anti-266
NSE; this is demonstrated in figure 5a.267
268
In each investigation, an array of twelve dots was imaged with a surface profile being269
obtained for each separate dot. The twelve profiles could be combined to give a mean270
peak magnitude response for these dots. Figure 5a shows the mean traces for 12 dotted271
samples, exposed to a variety of concentrations (0.5-200 pg ml-1) of NSE and it is clear272
that an increase in tip current as the concentration of antigen increases occurs over the273
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modified regions. For 200 pg mL-1 the dot profile appears larger and this is believed to be274
due to saturation of the area resulting in a much greater level of non-specific binding to275
the carbon being observed. There is also sign of the dot swelling in size at 20 and 50 pg276
mL-1 antigen concentration however, at the lower concentrations (0.5-5 pg mL-1) there277
is clearly very little change in current to the carbon region. Figure 5b shows a calibration278
profile obtained by plotting the peak mean dot responses with respect to antigen279
concentration. A linear relationship can be seen between the response and the log of the280
concentration in the range 0.5 pg mL-1 to 200 pg mL-1. A logarithmic relationship has281
also been found between ac impedance and antigen concentration in previous282
immunosensor work [8,10]. This demonstrates the potential for this technique to detect283
and quantify the presence of a target in solution.284
285
The limits of detection for NSE in this experiment (0.5 pg mL-1 to 200 pg mL-1) are286
comparable to those obtained with sonochemically microfabricated arrays (0.5 pg mL-1)287
[12] - and substantially lower than we obtained for similar systems based on288
macroelectrodes [7,8,10]. Previous work has succeeded in imaging layers of immobilised289
antibodies [34], however their technique required the use of enzyme modified antigens290
and also only reported the use of excess labelled antigen whereas our technique is label-291
free and is capable of producing a calibration curve. The sensitivity of our method also292
compares well with fluorescence based assays, for example when microarrays on silicon293
were utilised, antibody-peptide specific interactions could be observed with a detection294
limit of 0.5-1 ng mL-1 [35, 36].295
296
14
The key significance of this work is that for the first time we have demonstrated the297
feasibility of SECM antibody based arrays for the development of high throughput298
labeless affinity based analysis. This highly simplified approach could in some contexts299
directly challenge the fluorescence based approach for molecular diagnostic and/or other300
applications.301
302
4. Conclusions303
304
We have within this paper demonstrated the potential for utilising the SECM to image305
arrays of immobilised antibodies and furthermore detect binding of the antigen using a306
label-free protocol. A clear relationship between the antigen concentration and the307
changes in the signals obtained for binding to the arrays is observed. A calibration profile308
showed a clear correlation of change in current with respect to antigen concentration with309
detection limits of 0.5 pg mL-1 to 200 pg mL-1 . The low (pg mL-1) limits of detection will310
aid in the analysis of physiological samples since they can be diluted before use therefore311
diminishing the effects of interferents.312
313
The results obtained within this work demonstrate the feasibility of using the SECM to314
analyse surface binding of antigens. This technique although slower than fluorescent315
methods, has a significantly lower cost base and does not require labelling of any kind,316
including fluorescence of samples. Further work to be conducted will include the317
improvement of the preparation of arrays to increase the number of samples being tested318
at one time and also to allow for ‘control dots’ being incorporated within an array.319
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Figure Captions426
427
Figure 1. (a) Schematic representation of SECM instrumentation- the microelectrode428
probe is clamped into a high resolution XYZ micropositioning device and scanned across429
the sample surface. Scan parameters and tip electrochemistry are controlled via a PC430
interface. (b) The arrangement of electrodes in the electrochemical cell – i.e. WE, RE and431
the CE. (c) Redox coupling of ferrocene carboxylic acid between the microelectrode tip432
and the substrate.433
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434
Figure 2. Photograph of biotinylated PEI deposition on carbon electrode by pulled435
microcapillary using the XYZ micro-positioning stage of the SECM270 and of the final436
array pattern on the screen printed carbon electrode surface (dot size ~ 200 µm).437
438
Figure 3. Area scan of PEI/avidin/biotinylated antibody arrays on screen printed carbon439
electrode (a) before and (b) following rinsing and 30 mins exposure to water; (c) absolute440
change in measured current. (Scan rate was 10 µm per step). (Note Z axis scales are in441
reverse for visual aid).442
443
Figure 4. SECM scan of a PEI/avidin/biotinylated antibody array on a screen-printed444
carbon electrode; (a) following exposure to biotinylated antibody NSE, (b) following445
further exposure to complementary NSE antigen at 200 pg mL-1, (c) absolute change in446
measured current. (Scan rate was 10 µm per step). (Note Z axis scales are in reverse for447
visual aid).448
449
Figure 5. (a) Mean changes of a twelve dot array scan (n = 12) taken over450
PEI/avidin/biotinylated antibody surface area to various antigen concentrations (no error451
bars are included for clarity, data points on individual curves represent the tip current452
values taken in different sites of the dots); (b) Calibration plot showing changes in current453
measured (n = 12) vs. NSE concentration. Equation is y = 0.54ln(x) + 0.51, R2=0.97 and454
the error bars show the standard deviation between the 12 individual dots.455
456
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